PubRank

Ambrose Talisuna

Author PubWeight™ 56.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 2004 9.27
2 Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg 2006 5.91
3 Malaria case-management under artemether-lumefantrine treatment policy in Uganda. Malar J 2008 3.73
4 Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS One 2008 2.78
5 Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin Trials 2006 2.72
6 Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts. Acta Trop 2011 2.46
7 Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS One 2009 2.43
8 Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PLoS Med 2005 2.33
9 The World Bank: false financial and statistical accounts and medical malpractice in malaria treatment. Lancet 2006 2.22
10 Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence. Malar J 2007 2.08
11 Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. J Infect Dis 2006 1.93
12 Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy. Am J Trop Med Hyg 2005 1.59
13 Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda. Am J Trop Med Hyg 2005 1.53
14 Spatio-temporal patterns in kdr frequency in permethrin and DDT resistant Anopheles gambiae s.s. from Uganda. Am J Trop Med Hyg 2010 1.49
15 The implementation of Integrated Disease Surveillance and Response in Uganda: a review of progress and challenges between 2001 and 2007. Health Policy Plan 2012 1.45
16 Case management of severe malaria--a forgotten practice: experiences from health facilities in Uganda. PLoS One 2011 1.39
17 Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria. Malar J 2014 1.24
18 Integrated prevalence mapping of schistosomiasis, soil-transmitted helminthiasis and malaria in lakeside and island communities in Lake Victoria, Uganda. Parasit Vectors 2011 1.22
19 Quality of parental consent in a Ugandan malaria study. Am J Public Health 2005 1.19
20 Double ethical review of North-South collaborative clinical research: hidden paternalism or real partnership? Trop Med Int Health 2011 1.16
21 Complexity of Plasmodium falciparum infections and antimalarial drug efficacy at 7 sites in Uganda. J Infect Dis 2006 1.11
22 Challenges of non-commercial multicentre North-South collaborative clinical trials. Trop Med Int Health 2012 1.09
23 A path to an optimal future for the Affordable Medicines Facility-malaria. Health Policy Plan 2011 1.05
24 Impact of mass measles campaigns among children less than 5 years old in Uganda. J Infect Dis 2003 0.89
25 The feasibility, patterns of use and acceptability of using mobile phone text-messaging to improve treatment adherence and post-treatment review of children with uncomplicated malaria in western Kenya. Malar J 2014 0.89
26 Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria. Malar J 2012 0.86
27 Multiplicity of Plasmodium falciparum infection predicts antimalarial treatment outcome in Ugandan children. Afr Health Sci 2008 0.85
28 Parasite-based malaria diagnosis: are health systems in Uganda equipped enough to implement the policy? BMC Public Health 2012 0.84